01—History
Other Non-current Liabilities History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $285.0M
2 older moves run past ±150% (largest +2433.3%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is Moderna, Inc.'s current other non-current liabilities?
Moderna, Inc. (MRNA) annual other non-current liabilities for 2025 was $285.0M, a 6.74% increase from 2024. Moderna, Inc. other non-current liabilities for the quarter ending March 31, 2026 was $283.0M.
What was Moderna, Inc.'s other non-current liabilities in 2024?
Moderna, Inc. annual other non-current liabilities for 2024 was $267.0M, a 4.30% increase from 2023.
What was Moderna, Inc.'s other non-current liabilities in 2023?
Moderna, Inc. annual other non-current liabilities for 2023 was $256.0M, a 89.63% increase from 2022.
What is Moderna, Inc.'s 5-year other non-current liabilities CAGR?
Moderna, Inc. other non-current liabilities grew at a compound annual growth rate (CAGR) of 148.62% from FY2020 to FY2025, going from $3.0M to $285.0M over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)